ArticleCancers2022

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer.

Ethan A Burns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.